NL8103680A - Eukaryotisch autonoom replicerend segment. - Google Patents

Eukaryotisch autonoom replicerend segment. Download PDF

Info

Publication number: NL8103680A
Authority: NL; Netherlands
Prior art keywords: ars; hybrid; gene; eukaryotic; host
Prior art date: 1980-08-05

Application number

NL8103680A

Other languages

English (en)

Dutch (nl)

Original Assignee

Univ Leland Stanford Junior

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-08-05

Filing date

1981-08-04

Publication date

1982-03-01

1981-08-04 Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior

1982-03-01 Publication of NL8103680A publication Critical patent/NL8103680A/nl

Links

230000003362 replicative effect Effects 0.000 title claims description 18
108090000623 proteins and genes Proteins 0.000 claims description 83
108020004414 DNA Proteins 0.000 claims description 64
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 47
238000000034 method Methods 0.000 claims description 31
235000020669 docosahexaenoic acid Nutrition 0.000 claims description 30
210000004027 cell Anatomy 0.000 claims description 28
210000000349 chromosome Anatomy 0.000 claims description 24
241000206602 Eukaryota Species 0.000 claims description 23
239000012634 fragment Substances 0.000 claims description 23
230000010354 integration Effects 0.000 claims description 21
230000014509 gene expression Effects 0.000 claims description 17
230000010076 replication Effects 0.000 claims description 15
210000003527 eukaryotic cell Anatomy 0.000 claims description 12
230000001131 transforming effect Effects 0.000 claims description 10
230000015572 biosynthetic process Effects 0.000 claims description 9
238000003780 insertion Methods 0.000 claims description 9
230000037431 insertion Effects 0.000 claims description 9
239000000203 mixture Substances 0.000 claims description 9
102000004190 Enzymes Human genes 0.000 claims description 8
108090000790 Enzymes Proteins 0.000 claims description 8
108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
230000000295 complement effect Effects 0.000 claims description 6
230000002068 genetic effect Effects 0.000 claims description 6
210000005253 yeast cell Anatomy 0.000 claims description 6
241000196324 Embryophyta Species 0.000 claims description 5
102000004169 proteins and genes Human genes 0.000 claims description 5
241000251539 Vertebrata <Metazoa> Species 0.000 claims description 3
230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 3
230000002255 enzymatic effect Effects 0.000 claims description 3
240000008042 Zea mays Species 0.000 claims description 2
230000008878 coupling Effects 0.000 claims description 2
238000010168 coupling process Methods 0.000 claims description 2
238000005859 coupling reaction Methods 0.000 claims description 2
238000012258 culturing Methods 0.000 claims 3
238000001727 in vivo Methods 0.000 claims 2
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims 1
235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
210000001520 comb Anatomy 0.000 claims 1
235000013305 food Nutrition 0.000 claims 1
238000013467 fragmentation Methods 0.000 claims 1
238000006062 fragmentation reaction Methods 0.000 claims 1
235000009973 maize Nutrition 0.000 claims 1
239000002207 metabolite Substances 0.000 claims 1
230000009466 transformation Effects 0.000 description 17
101150009006 HIS3 gene Proteins 0.000 description 16
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 14
239000013598 vector Substances 0.000 description 14
238000002360 preparation method Methods 0.000 description 11
238000012217 deletion Methods 0.000 description 10
230000037430 deletion Effects 0.000 description 10
239000003550 marker Substances 0.000 description 10
239000013612 plasmid Substances 0.000 description 9
108091008146 restriction endonucleases Proteins 0.000 description 8
238000009396 hybridization Methods 0.000 description 7
230000035772 mutation Effects 0.000 description 7
238000003776 cleavage reaction Methods 0.000 description 6
230000007017 scission Effects 0.000 description 6
229920001817 Agar Polymers 0.000 description 5
241000588724 Escherichia coli Species 0.000 description 5
239000008272 agar Substances 0.000 description 5
230000006798 recombination Effects 0.000 description 5
238000005215 recombination Methods 0.000 description 5
101100285000 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) his-3 gene Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
238000007792 addition Methods 0.000 description 4
150000001413 amino acids Chemical class 0.000 description 4
230000029087 digestion Effects 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
108010042407 Endonucleases Proteins 0.000 description 3
102000004533 Endonucleases Human genes 0.000 description 3
108060002716 Exonuclease Proteins 0.000 description 3
102000003960 Ligases Human genes 0.000 description 3
108090000364 Ligases Proteins 0.000 description 3
241001599018 Melanogaster Species 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
229960000723 ampicillin Drugs 0.000 description 3
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
210000000941 bile Anatomy 0.000 description 3
102000013165 exonuclease Human genes 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
101100479039 Caenorhabditis elegans aars-1 gene Proteins 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
241000221961 Neurospora crassa Species 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
238000003491 array Methods 0.000 description 2
230000002567 autonomic effect Effects 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
230000008859 change Effects 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000008103 glucose Substances 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
108010056929 lyticase Proteins 0.000 description 2
239000006152 selective media Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
229930101283 tetracycline Natural products 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
238000000844 transformation Methods 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
101150029129 AR gene Proteins 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
235000007575 Calluna vulgaris Nutrition 0.000 description 1
UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
241000579120 Coliiformes Species 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
241001362614 Crassa Species 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
241000168726 Dictyostelium discoideum Species 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
108010001496 Galectin 2 Proteins 0.000 description 1
102100024637 Galectin-10 Human genes 0.000 description 1
102100021735 Galectin-2 Human genes 0.000 description 1
101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
229920011425 Gentro Polymers 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
101100281686 Mus musculus Fstl1 gene Proteins 0.000 description 1
108010047956 Nucleosomes Proteins 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
108091036333 Rapid DNA Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
101100097319 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ala1 gene Proteins 0.000 description 1
101150073336 Sycp1 gene Proteins 0.000 description 1
101150006914 TRP1 gene Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
241000700605 Viruses Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
229950006790 adenosine phosphate Drugs 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000000137 annealing Methods 0.000 description 1
-1 anti-cellin Natural products 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000005336 cracking Methods 0.000 description 1
GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
239000000835 fiber Substances 0.000 description 1
ZDPUTNZENXVHJC-UUOKFMHZSA-N guanosine 3'-monophosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O ZDPUTNZENXVHJC-UUOKFMHZSA-N 0.000 description 1
235000013928 guanylic acid Nutrition 0.000 description 1
239000004226 guanylic acid Substances 0.000 description 1
230000026030 halogenation Effects 0.000 description 1
238000005658 halogenation reaction Methods 0.000 description 1
101150107671 hisB gene Proteins 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000005286 illumination Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000000394 mitotic effect Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
210000001623 nucleosome Anatomy 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
239000002243 precursor Substances 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
101150116440 pyrF gene Proteins 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000006722 reduction reaction Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000032537 response to toxin Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000007320 rich medium Substances 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
238000010008 shearing Methods 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
239000013638 trimer Substances 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
230000001228 trophic effect Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NL8103680A 1980-08-05 1981-08-04 Eukaryotisch autonoom replicerend segment. NL8103680A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17554780A	1980-08-05	1980-08-05
US17554780		1980-08-05

Publications (1)

Publication Number	Publication Date
NL8103680A true NL8103680A (nl)	1982-03-01

Family

ID=22640660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8103680A NL8103680A (nl)	1980-08-05	1981-08-04	Eukaryotisch autonoom replicerend segment.

Country Status (7)

Country	Link
EP (1)	EP0045573A3 (de)
JP (1)	JPS57163395A (de)
CA (1)	CA1202918A (de)
DE (1)	DE3131034A1 (de)
IL (1)	IL63270A0 (de)
NL (1)	NL8103680A (de)
SE (1)	SE8104700L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4508823A (en) *	1980-05-08	1985-04-02	Microlife Technics, Inc.	Gene splicing method and products produced therefrom
JPS57129691A (en) *	1980-09-22	1982-08-11	Yunibaashiteii Obu Sazan Karif	Rearranged dna active in nuclear cell and preparation thereof
DE3381090D1 (de) *	1982-05-19	1990-02-15	Gist Brocades Nv	Klonierungssystem fuer kluyveromyce spezies.
GB2125047B (en) *	1982-08-09	1986-02-19	Ciba Geigy Ag	Yeast hybrid vectors and their use for the production of polypeptides
NO172595C (no) *	1983-02-07	1993-08-11	Battelle Memorial Institute	Fremgangsmaate og ekspresjonsplasmid for fremstilling av hemagglutinin under kontroll av drosophila hsp-promoter
NZ207765A (en) *	1983-04-15	1987-03-06	Lubrizol Genetics Inc	Plant expression of transferred dna(t-dna)from plasmids associated with agrobacterium sp
US5639639A (en) *	1983-11-02	1997-06-17	Genzyme Corporation	Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
ATE136057T1 (de) *	1986-07-24	1996-04-15	Daiichi Seiyaku Co	Autonom replizierende dna fragmente aus säugerzellen mit affinität zu dna bindenden proteinen
US5364761A (en) *	1986-07-24	1994-11-15	Daiichi Pharmaceutical Co., Ltd.	Method for isolating a DNA encoding an autonomously replicating sequence
CA1340772C (en)	1987-12-30	1999-09-28	Patricia Tekamp-Olson	Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
FR2626584B1 (fr) *	1988-01-28	1990-07-13	Agronomique Inst Nat Rech	Sequence ars efficace chez yarrowia lipolytica et procede pour sa preparation
EP2042196B1 (de)	2001-10-10	2016-07-13	ratiopharm GmbH	Neumodellierung und Glykokonjugation von Granulozyten-Kolonie stimulierender Faktor (G-CSF)
NZ542586A (en)	2003-04-09	2009-11-27	Biogenerix Ag	Method of forming a covalent conjugate between a G-CSF peptide and PEG
EP2380905A1 (de)	2010-04-19	2011-10-26	Thrombotargets Europe, S.L.	Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL63035A (en) *	1980-09-09	1985-05-31	Univ California	Dnas capable of replication and stable mitotic maintenance in a host eukaryote,their preparation and eukaryotic cells comprising them
JPS57129691A (en) *	1980-09-22	1982-08-11	Yunibaashiteii Obu Sazan Karif	Rearranged dna active in nuclear cell and preparation thereof

1981
- 1981-07-09 IL IL63270A patent/IL63270A0/xx unknown
- 1981-07-10 EP EP81303155A patent/EP0045573A3/de not_active Withdrawn
- 1981-07-23 CA CA000382368A patent/CA1202918A/en not_active Expired
- 1981-08-04 NL NL8103680A patent/NL8103680A/nl not_active Application Discontinuation
- 1981-08-05 SE SE8104700A patent/SE8104700L/ not_active Application Discontinuation
- 1981-08-05 JP JP56121992A patent/JPS57163395A/ja active Pending
- 1981-08-05 DE DE19813131034 patent/DE3131034A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
SE8104700L (sv)	1982-02-06
CA1202918A (en)	1986-04-08
EP0045573A2 (de)	1982-02-10
JPS57163395A (en)	1982-10-07
IL63270A0 (en)	1981-10-30
DE3131034A1 (de)	1982-06-16
EP0045573A3 (de)	1982-12-01

Legal Events

Date	Code	Title	Description
1984-04-02	BV	The patent application has lapsed

Publication	Publication Date	Title
US5869239A (en)	1999-02-09	Library screening method
Clarke et al.	1978	Functional expression of cloned yeast DNA in Escherichia coli: specific complementation of argininosuccinate lyase (argH) mutations
US6573046B1 (en)	2003-06-03	Eukaryotic use of improved chimeric mutational vectors
JP2552809B2 (ja)	1996-11-13	自律複製配列を有するｄｎａ断片、同断片を含有するハイブリッドプラスミド、同ハイブリッドプラスミドにより形質転換した大腸菌及び当該ｄｎａ断片の製造方法
US5783385A (en)	1998-07-21	Method for homologous-recombination screening of recombinant-DNA clones in yeast host libraries
US5212087A (en)	1993-05-18	Ars sequence which is efficacious in yarrowia lipolytica
US6232112B1 (en)	2001-05-15	Reagents and methods for diversification of DNA
EP0045573A2 (de)	1982-02-10	Eukaryotisches Segment mit autonomer Replikation
US7115413B2 (en)	2006-10-03	Meiotic recombination in vivo of partially homologous DNA sequences
Paietta et al.	1987	Molecular cloning and characterization of the cys-3 regulatory gene of Neurospora crassa
AU8171087A (en)	1988-05-25	Gene amplification using retrotransposons
US4464472A (en)	1984-08-07	Construction and use of functional minichromosomes
US4477571A (en)	1984-10-16	Chimeric plasmids that replicate in bacteria and yeast and microorganisms transformed therewith
EP0048081A2 (de)	1982-03-24	DNS, fähig zur Replikation und zur stabilen mitotischen Instandhaltung in einem eukaryotischen Wirt, Verfahren zu ihrer Herstellung und diese enthaltende eukaryotische Zelle
CN102292442A (zh)	2011-12-21	粟酒裂殖酵母的转化方法、转化体以及异源蛋白质的制造方法
EP0596885B1 (de)	1997-09-03	Methode zum screening einer dna bibliothek
Case	1982	Selective deletion of large segments of Balbiani ring DNA during molecular cloning
JPH07289262A (ja)	1995-11-07	部位特異的変異導入方法
JP2021019565A (ja)	2021-02-18	アスペルギルス属糸状菌のピリチアミン耐性変異株
Symington et al.	1984	Genetic recombination catalyzed by cell-free extracts of Saccharomyces cerevisiae
EP0472286A1 (de)	1992-02-26	Plasmamembran H+ATPase von Candida albicans kodierendem Gen
Ferencz	2024	Using DNA Looping Proteins to Enhance Homology Directed Repair In Vivo Following a Cas9 Induced Double Strand Break
WO2024122646A1 (ja)	2024-06-13	ゲノム編集された細胞の作製方法及び交雑促進方法
CN113462681A (zh)	2021-10-01	一种构建dna片段敲除文库的方法
Lee	1984	Characterization of two cysteine transfer RNA genes from Xenopus Laevis